Novel exosome-related risk signature as prognostic biomarkers in glioblastoma

Exosomes are progressively being detected as an indicator for the diagnosis and prognosis of cancer in clinical settings. Many clinical trials have confirmed the impact of exosomes on tumor growth, particularly in anti-tumor immunity and immunosuppression of exosomes. Therefore, we developed a risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Mingyan, Xu, Qiang, Jin, Xiuying, Han, Zhezhu, Jiang, Hao, Sun, Honghua, Jin, Yongmin, Piao, Zhengri, Zhang, Songnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971586/
https://www.ncbi.nlm.nih.gov/pubmed/36865549
http://dx.doi.org/10.3389/fimmu.2023.1071023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971586/
https://www.ncbi.nlm.nih.gov/pubmed/36865549
http://dx.doi.org/10.3389/fimmu.2023.1071023

Ejemplares similares